This panel will focus on the importance of FDA compliance evidence at trial. The COVID-19 pandemic has profoundly changed public attitudes, perceptions and expectations of the life sciences industry in numerous ways. The average juror is more educated about the FDA, clinical trials, manufacture to market timelines, and regulatory compliance than ever before. With this knowledge comes an expectation that medical device and pharmaceutical companies have - at the very least - complied with FDA regulations before marketing their products to the public. Therefore, at a trial involving medical devices, it is paramount to a fair trial that device manufacturers are permitted to introduce evidence of their compliance with FDA pre-market requirements.